Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors
Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
This study will gather information about the combination the drugs plerixafor with
sargramostim in donors of blood-forming cells (stem cells). These stem cells will be
collected from the donor and transplanted into their sibling. The investigators believe that
the two drugs together will provide enough stem cells for transplantation and may also reduce
the risk of graft versus host disease.